» Articles » PMID: 7637258

Angiotensin II Receptor Antagonist Ameliorates Renal Tubulointerstitial Fibrosis Caused by Unilateral Ureteral Obstruction

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1995 May 1
PMID 7637258
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Unilateral ureteral obstruction (UUO) results in tubulointerstitial fibrosis of the obstructed kidney (OBK). In this study we report that a specific angiotensin II (Ang II) receptor antagonists, SC-51316, ameliorates the expansion of the renal cortical interstitium in the OBK of the rat at five days of UUO. This is similar to the effect of an angiotensin converting enzyme (ACE) inhibitor, enalapril. SC-51316 (20 mg/liter in the drinking water) or enalapril (200 mg/liter in the drinking water) was administered beginning 24 hours before UUO and continued through five days after UUO. The relative volume of the tubulointerstitium (Vv) was measured by a point-counting method, and monocyte/macrophage infiltration, alpha smooth muscle actin (alpha SMA), proliferating cell nuclear antigen (PCNA), and collagen type IV (collagen IV) protein deposition were examined histologically using specific antibodies. We also examined the mRNA levels of transforming growth factor beta 1 (TGF-beta 1) and collagen IV by reverse transcription polymerase chain reaction. In untreated rats with UUO, Vv was remarkably expanded; collagen IV and alpha SMA protein deposition in the interstitium and PCNA labeling of nuclei were increased. These changes were significantly ameliorated by administration of an ACE inhibitor or an Ang II receptor antagonist. A monocyte/macrophage infiltration was evident in the OBK of untreated or Ang II receptor antagonist treated rats but was greatly reduced in the OBK of rats given enalapril. Increased expression of TGF-beta 1 mRNA and collagen IV mRNA was blunted (40 to 75%) by the administration of Ang II receptor antagonist or enalapril. The Ang II receptor antagonist or the ACE inhibitor did not affect the contralateral kidney of rats with UUO or the control kidney of normal rats. This study indicates that the renin-angiotensin system has a major role in the pathogenesis of the tubulointerstitial fibrosis of obstructive nephropathy. The tubulointerstitial fibrosis of obstructive nephropathy is most likely mediated by an increased level of Ang II in renal tissue.

Citing Articles

Can We Predict Renal Function Recovery After Pyeloplasty in Pediatrics with Ureteropelvic Junction Obstruction? A Systematic Review.

Siregar S, Mustafa A, Steven S Urol Res Pract. 2024; .

PMID: 38798006 PMC: 11265535. DOI: 10.5152/tud.2024.23220.


Repurposing of Angiotensin-converting-enzyme Inhibitor on Prevention of Post-surgical Tendon Adhesion.

Naimi H, Khazaei M, Sharifnia F, Sayyed-Hosseinian S Curr Pharm Des. 2024; 30(11):859-867.

PMID: 38468533 DOI: 10.2174/0113816128284671240214080516.


Kidney Renin Release under Hypoxia and Its Potential Link with Nitric Oxide: A Narrative Review.

Kong W, Liao Y, Zhao L, Hall N, Zhou H, Liu R Biomedicines. 2023; 11(11).

PMID: 38001984 PMC: 10669676. DOI: 10.3390/biomedicines11112984.


Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis.

Norregaard R, Mutsaers H, Frokiaer J, Kwon T Physiol Rev. 2023; 103(4):2827-2872.

PMID: 37440209 PMC: 10642920. DOI: 10.1152/physrev.00027.2022.


The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.

Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.

PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.